Medidata’s global event series of the year—NEXT Global 2021—brought together industry leaders, life sciences change-makers, and patient advocates to map the future of drug development. This global event included keynotes, live and interactive roundtable discussions, breakout sessions, lightning talks, customer success stories, and product demonstrations.

In this eBook, we’ve compiled highlights of the most popular sessions that focused on artificial intelligence (AI)-powered technologies for clinical trials. The sessions explored the use of AI for generating Synthetic Control Arms (SCAs) to reduce enrollment and de-risk studies, uniting a clinical trial management system (CTMS) with analytics for study planning and oversight, the creation of valuable, longitudinal patient data, and AI-innovations to support clinical trial innovation.